| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.073 | 0.4 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |